2020
DOI: 10.3892/mmr.2020.11678
|View full text |Cite
|
Sign up to set email alerts
|

Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 33 publications
1
1
0
Order By: Relevance
“…Based on findings from this study, PARP1 expression may also contribute to carcinogenesis, in addition to its enzymatic activity (40). Additionally, our findings show the distribution of this gene in ovarian cancer cells, which could be useful for the treatment of ovarian cancer.…”
Section: Scrna-seq Was Used To Examine Gene Expression Patterns Fromsupporting
confidence: 59%
“…Based on findings from this study, PARP1 expression may also contribute to carcinogenesis, in addition to its enzymatic activity (40). Additionally, our findings show the distribution of this gene in ovarian cancer cells, which could be useful for the treatment of ovarian cancer.…”
Section: Scrna-seq Was Used To Examine Gene Expression Patterns Fromsupporting
confidence: 59%
“…The Warburg effect, demonstrated by increased glycolytic intermediate labeling, decreased pyruvate dehydrogenase flow and decreased tricarboxylic acid cycle labeling, has been observed in various primary ccRCC cases (100). By regulating PARP1 expression, lipid metabolism-associated drugs simvastatin and tanshinone I inhibit proliferation of melanoma and renal tumour cells (101). Therefore, PARP inhibition may exert a synergistic inhibitory effect on tumor growth of ccRCC with other metabolic inhibitory molecules (97).…”
Section: Ddr Genes and Precision Treatment Of Renal Cancermentioning
confidence: 99%